Day One Biopharmaceuticals
DAWN
DAWN
45 hedge funds and large institutions have $453M invested in Day One Biopharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 12 increasing their positions, 7 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
45
Holders Change
+12
Holders Change %
+36.36%
% of All Funds
0.79%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
20
Increased
12
Reduced
7
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
DM
Deerfield Management
New York
|
$40.6M |
| 2 |
BlackRock
New York
|
$12.4M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
$19.5M |
| 4 |
Millennium Management
New York
|
$4.22M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
$4.43M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
51
Goldman Sachs
New York
| – | -$264K | -11,594 | Closed |
|
|
ECM
52
ExodusPoint Capital Management
New York
| – | -$213K | -9,372 | Closed |
|
|
MS
53
Maven Securities
St Helier,
Jersey
| – | -$210K | -9,000 | Closed |
|